1983
DOI: 10.1136/gut.24.4.326
|View full text |Cite
|
Sign up to set email alerts
|

Effects of porcine gastric fundic factor, somatostatin, substance P, glucagon, neurotensin, bombesin, VIP, motilin, and pentagastrin on jejunal glucose absorption in the rat.

Abstract: SUMMARY The effects of a porcine gastric fundic mucosal extract (molecular weight <10 000) has been compared with the effects of eight candidate gastrointestinal peptides on glucose absorption from the jejunum in a rat model. Bolus injection of the extract produced immediate and marked depression of glucose absorption. None of the candidate peptides tested produced this response, although somatostatin and substance P depressed absorption as a late phenomenon after 30 minutes. We conclude that the effects of th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1986
1986
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…The following treatments were infused into the lumen of the upper small intestine during the basal insulin euglycemic clamp at a rate of 2 mL/min for 50 min: 1) saline, 2-6) glucose, fructose, galactose, 3-O-methyl glucose, sucralose (2 mM, Sigma-Aldrich, St. Louis, MO, USA), 7) phlorizin (50 mM; 40 pmol min-1; Sigma Aldrich), 8) MK-329 (979 mM; 2 nmol min-1; Tocris Bioscience), 9) Exendin-9 (75 mg mL À1 ; 0.15 mg min À1 ; Tocris Bioscience). Intestinal glucose is absorbed from the lumen into the small intestinal mucosa at a rate of 600 nmol min-1 in rats at comparable weight (250 g) (Andrews et al, 1983). A lower glucose dose of 20 nmol min-1 was originally used in a previous study from our lab investigating the effects of a glucose infusion into the lower jejunum (Breen et al, 2012).…”
Section: Treatmentsmentioning
confidence: 99%
“…The following treatments were infused into the lumen of the upper small intestine during the basal insulin euglycemic clamp at a rate of 2 mL/min for 50 min: 1) saline, 2-6) glucose, fructose, galactose, 3-O-methyl glucose, sucralose (2 mM, Sigma-Aldrich, St. Louis, MO, USA), 7) phlorizin (50 mM; 40 pmol min-1; Sigma Aldrich), 8) MK-329 (979 mM; 2 nmol min-1; Tocris Bioscience), 9) Exendin-9 (75 mg mL À1 ; 0.15 mg min À1 ; Tocris Bioscience). Intestinal glucose is absorbed from the lumen into the small intestinal mucosa at a rate of 600 nmol min-1 in rats at comparable weight (250 g) (Andrews et al, 1983). A lower glucose dose of 20 nmol min-1 was originally used in a previous study from our lab investigating the effects of a glucose infusion into the lower jejunum (Breen et al, 2012).…”
Section: Treatmentsmentioning
confidence: 99%
“…14 15 In addition, jejunal glucose absorption has also been shown to be decreased by substance P in vivo. 28 Other, as yet untested mechanisms of action include the central and/or peripheral neurologic effects of substance P as well as its interactions with other gastrointestinal peptides. Humoural mediation is suggested by the reports of a suppressive effect of substance P on gastric somatostatin release29 30 Along with other neurohumoural substances that alter intestinal transport, such as serotonin and neurotensin, substance P appears to effect intestinal transport by increasing Ca" + entry across the basolateral membrane of intestinal epithelial cells.32 3 Its secretory effects are unaffected in vitro by atropine, indomethacin, diphenhydramine, and somatostatin, but can be reversed by removal of extracellular Ca++ ions or the addition of Verapamil, a calcium-channel blocker, to the serosal bathing solution.…”
Section: Discussionmentioning
confidence: 99%
“…The basolateral membrane of enterocytes has receptors for cholecystokinin, gastrin, and other regulatory peptides associated with the GIT, which are known to modulate enterocyte absorption of ions (6)(7)(8)(9) and carrier-mediated uptake of glucose by the sodium-dependent transporter SGLT-l (10)(11)(12)(13)(14). Less is known about the responses to signaling molecules that originate from sources other than the GIT and associated organs.…”
mentioning
confidence: 99%